Wave Life Sciences Ltd. (WVE)

Wave Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	42.73	108.3	113.31	3.65	40.96
Revenue Growth (YoY)	-60.55%	-4.42%	3005.10%	-91.09%	104.03%
Gross Profit	42.73	108.3	113.31	3.65	40.96
Selling, General & Admin	75.33	59.02	51.29	50.51	46.11
Research & Development	182.78	159.68	130.01	115.86	121.88
Total Operating Expenses	258.11	218.71	181.3	166.37	167.98
Operating Income	-215.38	-110.4	-68	-162.72	-127.02
Other Non-Operating Income (Expense)	11.01	13.4	9.81	1.58	4.57
Total Non-Operating Income (Expense)	11.01	13.4	9.81	1.58	4.57
Pretax Income	-204.38	-97.01	-58.19	-161.14	-122.45
Provision for Income Taxes	-	-	0.68	-0.68	0.2
Net Income	-204.38	-97.01	-57.51	-161.82	-122.25
Net Income to Common	-204.38	-97.01	-57.51	-161.82	-122.25
Shares Outstanding (Basic)	169	138	106	79	52
Shares Outstanding (Diluted)	169	138	106	79	52
Shares Change (YoY)	21.96%	30.33%	34.55%	52.16%	32.12%
EPS (Basic)	-1.21	-0.70	-0.54	-2.05	-2.36
EPS (Diluted)	-1.21	-0.70	-0.54	-2.05	-2.36
Free Cash Flow	-188.21	-151.96	-20.55	-129.14	-89.55
Free Cash Flow Per Share	-1.12	-1.10	-0.19	-1.64	-1.73
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-504.09%	-101.94%	-60.01%	-4459.30%	-310.07%
Profit Margin	-478.33%	-89.57%	-50.76%	-4434.72%	-298.42%
FCF Margin	-440.50%	-140.32%	-18.13%	-3539.11%	-218.61%
EBITDA	-206.53	-101.74	-58.79	-152.61	-117.18
EBITDA Margin	-483.37%	-93.94%	-51.89%	-4182.13%	-286.06%
EBIT	-215.38	-110.4	-68	-162.72	-127.02
EBIT Margin	-504.09%	-101.94%	-60.01%	-4459.30%	-310.07%
Effective Tax Rate	0.00%	0.00%	-1.16%	0.42%	-0.17%

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q